Good Morning My 'Friends,
I just learned from another discussion group that the following was
posted for many of the clinical trials to be either conducted or is
ongoing as trials utilizing Dr. Ted Bruczinskis antineoplastons. You
will remember him as the very controversial Doctor who won a 15 year
battle with local enforcement authorities in Texas as well as the FDA in
a lawsuit to stop him from administering these treatments. WEll
successfully the NCI and the FDA has recognized some merit to his
therapy and trials are now ongoing. The folllowing are some of the
trials that will be studied.
God Bless
marty auslander
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With Chronic
Myelogenous Leukemia. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplaston A10 And As2-1 In Patients With Chronic
Lymphocytic Leukemia. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplatons A10 And As2-1 In Patients With
Malignant
Melenoma. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplatons A10 And As2-1 In Patients With
Malignant
Melenoma. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 In Patients With Primary Liver
Cancer. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Kidney. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Head And Neck. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Adenocarcinoma Of The Esophagus. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Adenocarcinoma Of The Colon. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Private Antineoplaston A10 And As2-1 Capsules In
Patients With Adenocarcinoma Of The Colon. This study is being conducted
in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Breast. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Private Antineoplaston A10 And As2-1 Capsules In
Patients With Advanced Breast Cancer. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Private Antineoplaston A10 In Combination With Low
Dose
Methotrexate In Patients With Advanced Breast Cancer. This study is
being
conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Bladder. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Adenocarcinoma Of The Pancreas. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Ovary. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Carcinoma Of The Uterine Cervix And/Or Vulva. This study is being
conducted
in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1In Patients With
Adenocarcinoma Of The Stomach. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
Phase II Study Of Antineoplastons A10 And As2-1 In Patients With
Mesothelioma. This study is being conducted in:
- Houston, TX
http://www.centerwatch.com/studies/LISTING.HTM
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
